Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Intercept Pharmaceuticals Inc (NASDAQ:ICPT)

60.73
Delayed Data
As of Nov 17
 0.00 / 0.00%
Today’s Change
54.98
Today|||52-Week Range
135.59
-44.10%
Year-to-Date
No recent news for Intercept Pharmaceuticals Inc.

Today’s Trading

Previous close60.73
Today’s open59.51
Day’s range59.51 - 61.22
Volume505,141
Average volume (3 months)1,303,418
Market cap$1.5B
Dividend yield--
Data as of 4:00pm ET, 11/17/2017

Growth & Valuation

Earnings growth (last year)-75.10%
Earnings growth (this year)+19.15%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+796.87%
P/E ratioNM
Price/Sales107.40
Price/Book4.79

Competitors

 Today’s
change
Today’s
% change
MDCOMedicines Co0.000.00%
AGIOAgios Pharmaceutical...0.000.00%
SAGESAGE Therapeutics In...0.000.00%
PBHPrestige Brands Hold...0.000.00%
Data as of 4:02pm ET, 11/17/2017

Financials

Next reporting dateFebruary 21, 2018
EPS forecast (this quarter)-$3.40
Annual revenue (last year)$25.0M
Annual profit (last year)-$412.8M
Net profit margin-1,654.56%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Mark E. Pruzanski
Chief Operating Officer
Jerome B. Durso
Corporate headquarters
New York, New York

Forecasts